BE Design [Design Issues]

posted by ElMaestro  – Denmark, 2014-09-25 11:57 (4293 d 21:28 ago) – Posting: # 13580
Views: 3,898

Hello Mahesh,

❝ If the product's BE guideline is not available in such cases can we design the protocol based on general guideline on BA/BE?


If there is no product-specific recommendation (that's what you mean isn't it?) then you should rely on the general BE guideline but of course it is a good idea to apply a minimum amount of independent thinking; is the product plain and simple or are you dealing with a nightmare like an inhalation product etc?

❝ Still do we need to make control correspondence with USFDA with BE study design and get approval before to proceed BE study?


No, controlled correspondence with FDA is a general option and not a requirement unless otherwise explicitly required by the FDA.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
356 visitors (0 registered, 356 guests [including 24 identified bots]).
Forum time: 09:25 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5